Sanford Health has chosen the Eviti platform from NantHealth Inc (NASDAQ:NH) as the platform through which it will carry out its web-based oncology decision as well as evidence-based treatment intelligence.
Black Book Market Research recently selected Eviti as the best Clinical Decision Support solution for 2016. The terms of the deal dictate that oncologists from Sanford Health’s network will have the eviti Connect decision support solution at their disposal. The solution will provide them with conditional specific clinical trial options and regimens based on evidence. It will also increase the chances of expedited reimbursement and more efficient preauthorization. The Eviti platform also opens up doors to deliver OMICS data designed for bio-specific therapy. The deal places Sanford Health in the same class as 75% of oncology practices in the US that have also employed the Eviti platform to make better decisions in their treatment processes.
Sanford Health will deploy Eviti across system-wide processes so that they can prescribe cost-effective and high-quality treatments. The company also plans to use the platform to enhance the flow of information between the health firm and its providers. The system will work towards providing benefits to cancer patients that participate in the cancer care process. Some of the benefits include lower costs and lower risks along with a real-time approach.
The firm will choose treatment plans that provide the optimal outcome so that it can cater to as many cancer patients as possible. The system is expected to feature supercomputing capacity such as data compilation and fast learning capabilities. The Eviti platform, in this case, is not difficult to use and it can handle large amounts of data at a speedy pace to offer rapid solutions. Kirk Zimmer, the executive VP of Sanford Health Plan stated that the firm is fully focused on offering the highest level of support to oncologists in its network so that they can, in turn, offer the best and most advanced patient care achievable.
